TIMI IIIB was a randomized trial comparing an invasive strategy of early catheterization, followed by revascularization as indicated to a conservative strategy of catheterization only with evidence of ...

Yet overall performance was good with both the ESC and High-STEACS strategies, leaving hospitals room to choose.

NEW ORLEANS, LA — In a study of more than 9000 patients who were hospitalized for non-ST-segment-elevation MI (NSTEMI), those who received early revascularization (within 24 hours) were more likely to ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...